Healthcare Sales & Marketing Network News: Elusys Therapeutics

Searching News Database: Elusys Therapeutics

HSMN NewsFeed - 2 Dec 2020
Obiltoxaximab Receives Marketing Authorization From European Commission For The Treatment Of Inhalation Anthrax
Biopharmaceuticals Regulatory

HSMN NewsFeed - 10 Mar 2008
Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jul 2007
Elusys Appoints New Chairman of the Board and a Vice President of Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2007
Elusys Names Jeremy D. Middleton Vice President of Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Apr 2007
Ambrilia Announces the Appointment of Stephen G. Sudovar as Executive Chairman & Interim CEO as Hans Mader is Stepping Down as President & CEO and a $5.4 Million Private Placement
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2007
Elusys Announces Collaborative Research and License Agreement with Pfizer
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Jul 2006
Elusys Therapeutics Completes $23 Million Series D Venture Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Jun 2006
Elusys' Anthrax Therapeutic, Anthim(TM), Granted FDA Orphan Drug Designation
Biopharmaceuticals FDA

Return to NewsFeed

Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 2 additional stories matching:
Elusys Therapeutics
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.